Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;31(4):244-9.
doi: 10.3343/kjlm.2011.31.4.244. Epub 2011 Oct 3.

Gonadotropin-releasing hormone stimulation test for precocious puberty

Han Kyul Kim  1 , Seung Jung Kee, Ji Yeon Seo, Eun Mi Yang, Hong Jae Chae, Chan Jong Kim
Affiliations

Gonadotropin-releasing hormone stimulation test for precocious puberty

Han Kyul Kim et al. Korean J Lab Med. 2011 Oct.

Abstract

Background: Gonadotropin-releasing hormone (GnRH) stimulation test is the gold standard to identify central precocious puberty (CPP). This test requires multiple blood samples at different time points to measure gonadotropin levels, and is therefore expensive, time-consuming, and uncomfortable for patients. We aimed to simplify the GnRH stimulation test to require fewer blood samples.

Methods: A study of 166 girls with precocious puberty was undertaken. Blood samples were obtained at 0, 15, 30, 45, 60, 90, and 120 min after GnRH administration, and the levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were measured. For each parameter, the sensitivities and specificities were estimated and ROC curves were constructed.

Results: One hundred and twenty-eight patients (77.1%) were diagnosed for CPP. Peak LH levels were achieved 30 min after GnRH stimulation in patients with CPP. Further, 98.4% of the 45-min samples were diagnostic for CPP, and the cumulative frequency of LH values of ≥5 IU/L was 100% at 45 min. Using this cut-off value for LH, the ROC curve for LH at 45 min showed the highest sensitivity (98.4%) and specificity (100%) in the diagnosis of CPP.

Conclusions: Values of LH measured from a single blood sample obtained at 45 min in the GnRH stimulation test may be adequate for the diagnosis of CPP. Two samples, taken at 30 and 45 min after stimulation, were able to accurately diagnose CPP in 100% of the patients in this study.

Keywords: Luteinizing hormone; Premature thelarche; Sexual precocity.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1
Comparison of basal (A) and peak (B) LH concentrations following GnRH stimulation, between CPP patients (N=128) and PT patients (N=38). Box-plots show the median, interquartile range, outliers, and extreme cases. Abbreviations: LH, luteinizing hormone; GnRH, gonadotropin releasing hormone; CPP, central precocious puberty; PT, premature thelarche.
Fig. 2
Fig. 2
Comparison of (A) LH and (B) FSH concentrations, and (C) LH/FSH ratio, versus time after GnRH stimulation, between CPP and PT patients. Data are presented as median and 95% CI. Abbreviations: LH, luteinizing hormone; FSH, follicle-stimulating hormone; GnRH, gonadotropin releasing hormone; CPP, central precocious puberty; PT, premature thelarche; CI, confidence intervals.
Fig. 3
Fig. 3
ROC curves of LH at different time points (30, 45, and 60 min) after stimulation in all patients. Abbreviations: LH, luteinizing hormone; AUC, area under curve; ROC, receiver operating characteristic.
See this image and copyright information in PMC

References

    1. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev. 2003;24:668–693. - PubMed
    1. Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, Antoniazzi F, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009;123:e752–e762. - PubMed
    1. Lee PA. Central precocious puberty. An overview of diagnosis, treatment, and outcome. Endocrinol Metab Clin North Am. 1999;28:901–918. - PubMed
    1. Partsch CJ, Heger S, Sippell WG. Management and outcome of central precocious puberty. Clin Endocrinol (Oxf) 2002;56:129–148. - PubMed
    1. Brito VN, Batista MC, Borges MF, Latronico AC, Kohek MB, Thirone AC, et al. Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab. 1999;84:3539–3544. - PubMed

Substances

LinkOut - more resources